Overview
- 10 public-safe observations are available for this inspection.
- 10 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
14 Jul 2017
21 CFR 111.12(c)
Personnel - education, training, experience
Cited by Omayra N Rodriguez-Ruiz
14 Jul 2017
21 CFR 111.140(b)(1)
Records - quality control operations; responsibilities
Cited by Omayra N Rodriguez-Ruiz
14 Jul 2017
21 CFR 111.205(c)
Master manufacturing record: readily available
Cited by Omayra N Rodriguez-Ruiz
Inspected site
DDDuy Drugs Inc.Doral, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 1.225 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.12(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.12(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.140(b)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.205(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.255(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.503 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.553 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.65 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 111.83(a) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 10 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere